Daejeon, South Korea

Soo Yong Chung

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 10.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Daejeon, KR (2011 - 2012)
  • Gyeonggi-do, KR (2021 - 2024)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Soo Yong Chung

Introduction

Soo Yong Chung is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of nine patents. His work focuses on developing novel compounds that enhance drug stability and bioavailability.

Latest Patents

One of his latest patents involves the salt of an aminopyridine derivative compound, specifically a mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide. This invention presents a novel crystalline form that demonstrates excellent stability, solubility, and bioavailability when administered alone or in combination with other drugs. The high purity of this compound further enhances its potential for pharmaceutical applications.

Career Highlights

Soo Yong Chung has worked with notable companies in the pharmaceutical industry, including LG Life Sciences and Yuhan Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Soo Yong Chung has collaborated with several professionals, including Koo Lee and Sang Dae Lee. These collaborations have played a crucial role in advancing his research and patent developments.

Conclusion

Soo Yong Chung's innovative work in the pharmaceutical field has led to significant advancements in drug formulation and delivery. His contributions continue to impact the industry positively, showcasing the importance of research and development in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…